Novartis acquisition of AveXis : Swiss pharma company Novartis has struck a $8.7 billion to acquire US gene therapy company AveXis in a move to bolster its gene therapy and neuroscience pipeline. Novartis Acquisition of AveXis As per the latest pharma acquisition news, Novartis has agreed to pay $218 for each of the AveXis shares. […]
The post Novartis to buy US gene therapy company AveXis for $8.7bn appeared first on Business News Today.